Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients
about
Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.Impaired NFKBIE gene function decreases cellular uptake of methotrexate by down-regulating SLC19A1 expression in a human rheumatoid arthritis cell line.Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cellsvia suppression of PGE2 and deactivation of Wnt/β-catenin signaling pathway.Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.
P2860
Q35791771-E93FF85C-CA5C-4637-99A6-2B10E2097E16Q36975907-B44015DD-5EC2-4649-8220-0F98A7E907A5Q37683906-66AF3866-41F3-4BA0-A60B-BBBB15CCFBCFQ37725354-0146FD3A-E0D2-4DFB-A849-D1577DD37E07Q38648460-2B1EE7C0-0B80-49C3-9659-F3D8974DF936Q38818138-DE829490-1200-420E-B05D-6AEAFB06507FQ38936379-391B568F-58CB-4F47-872C-57BB473F0099Q39043220-C2876236-5BE4-4417-84A1-1692B338D69AQ40564193-8F66F220-0255-4D33-8F19-1D97EC43DEDEQ47330961-C0C7FAEA-1194-45A0-B3D9-AA2BF90F0445Q49527931-689C076F-3D05-4544-9D00-83A03F0A5FB8Q53093606-74C397C9-1EEE-43A6-92EC-09954165870CQ53165185-79251630-5D2C-43C8-8AEA-EB59A64CE325
P2860
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@ast
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en-gb
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@nl
type
label
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@ast
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en-gb
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@nl
prefLabel
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@ast
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en-gb
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@nl
P2860
P50
P3181
P1433
P1476
Role of key TYMS polymorphisms ...... rheumatoid arthritis patients
@en
P2093
Miguel Bernardes
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0108165
P407
P577
2014-01-01T00:00:00Z